Skip to content
Recall Observatory FDA recall evidence

Drug product

Optiray 320 (ioversol) Injection 68%, 320 mg/mL Organically Bound Iodine, packaged in 1 - 100 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1323-00.

D-0137-2020

September 13, 2019

Class II

Product summary

Firm
GUERBET LLC
Event
Event 83798
Status
Terminated
Classification
Class II
Quantity
3860 syringes
Official record key
drug-enforcement:D-0137-2020

Official wording

Reason: Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.

Code information: Lots: L141C, L162A Exp. 06/2021; L146DS, Exp. 05/2021

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.

Field note

Send feedback

We'll only use this to respond to your feedback.